AU606582B2 - Methods for the recovery of tissue plasminogen activator - Google Patents

Methods for the recovery of tissue plasminogen activator Download PDF

Info

Publication number
AU606582B2
AU606582B2 AU63369/86A AU6336986A AU606582B2 AU 606582 B2 AU606582 B2 AU 606582B2 AU 63369/86 A AU63369/86 A AU 63369/86A AU 6336986 A AU6336986 A AU 6336986A AU 606582 B2 AU606582 B2 AU 606582B2
Authority
AU
Australia
Prior art keywords
intact
recited
substrate
solution
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU63369/86A
Other languages
English (en)
Other versions
AU6336986A (en
Inventor
Peter Donner
Michael John Morser
Craig W. Rice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare Pharmaceuticals Inc
Original Assignee
Codon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codon filed Critical Codon
Publication of AU6336986A publication Critical patent/AU6336986A/en
Application granted granted Critical
Publication of AU606582B2 publication Critical patent/AU606582B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63369/86A 1985-09-06 1986-09-05 Methods for the recovery of tissue plasminogen activator Ceased AU606582B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77333485A 1985-09-06 1985-09-06
US773334 1985-09-06

Publications (2)

Publication Number Publication Date
AU6336986A AU6336986A (en) 1987-03-24
AU606582B2 true AU606582B2 (en) 1991-02-14

Family

ID=25097914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63369/86A Ceased AU606582B2 (en) 1985-09-06 1986-09-05 Methods for the recovery of tissue plasminogen activator

Country Status (3)

Country Link
EP (1) EP0238551A4 (fr)
AU (1) AU606582B2 (fr)
WO (1) WO1987001389A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
US4960702A (en) * 1985-09-06 1990-10-02 Codon Methods for recovery of tissue plasminogen activator
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
PT84991B (pt) * 1986-06-06 1990-03-08 Genentech Inc Processo para a producao de actividador do plasminogenio biologicamente activo
WO1988000615A1 (fr) * 1986-07-16 1988-01-28 Celltech Limited Procede de purification d'un activateur de plasminogene
JPS6463378A (en) * 1986-08-11 1989-03-09 Mitsui Toatsu Chemicals Separation of single stranded tpa and double standard tpa
JPS6379591A (ja) * 1986-09-22 1988-04-09 Mitsui Toatsu Chem Inc ｔＰＡの精製方法
AU1668988A (en) * 1987-06-03 1988-12-08 Smithkline Beckman Corporation Purification of tpa
US4929560A (en) * 1988-02-03 1990-05-29 Damon Biotech, Inc. Recovery of tissue plasminogen activator
WO1990002175A1 (fr) * 1988-08-16 1990-03-08 Novo Nordisk A/S Procede de production de polypeptides par culture de cellules eukaryotiques en presence d'inhibiteurs de protease
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DK0485504T3 (da) * 1989-08-11 1994-04-18 Zymogenetics Inc Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041766A2 (fr) * 1980-06-11 1981-12-16 Leuven Research & Development V.Z.W. Nouveau activateur de plasminogène et composition pharmaceutique à activité thrombolytique
AU6000886A (en) * 1985-07-10 1987-01-15 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041766A2 (fr) * 1980-06-11 1981-12-16 Leuven Research & Development V.Z.W. Nouveau activateur de plasminogène et composition pharmaceutique à activité thrombolytique
AU6000886A (en) * 1985-07-10 1987-01-15 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor

Also Published As

Publication number Publication date
EP0238551A4 (fr) 1988-02-01
AU6336986A (en) 1987-03-24
EP0238551A1 (fr) 1987-09-30
WO1987001389A1 (fr) 1987-03-12

Similar Documents

Publication Publication Date Title
US4960702A (en) Methods for recovery of tissue plasminogen activator
EP0041766B1 (fr) Nouveau activateur de plasminogène et composition pharmaceutique à activité thrombolytique
EP0196920B1 (fr) Espèce dégradée d'activateur de plasminogène tissulaire, composition pharmaceutique et sa méthode de préparation
US4902623A (en) Plasminogen activator
AU606582B2 (en) Methods for the recovery of tissue plasminogen activator
JPH05170666A (ja) プロテインｃを含有し血栓溶解活性を有する非経口投与が可能な薬剤
JP2010540432A (ja) ヒト組織型プラスミノーゲンアクチベータの精製方法
FI96211B (fi) Menetelmä yksisäikeisen kudosplasminogeeniaktivaattorin (tPA) ja kaksisäikeisen tPA:n puhdistamiseksi ja eristämiseksi
US6001355A (en) Pro-tPA for the treatment of thrombosis, embolism and related conditions
CA1333163C (fr) Methodes d'isolement de l'activateur tissulaire du plasminogene
Bansal et al. Recovery of urokinase from integrated mammalian cell culture cryogel bioreactor and purification of the enzyme using p‐aminobenzamidine affinity chromatography
KR100508043B1 (ko) rDSPAα1의 제조방법
Verstraete The search for the ideal thrombolytic agent
NZ257175A (en) Thrombin activated plasminogen derivatives with the cleavage site p4-p3-pro-arg-p1'-p2'
US5723122A (en) Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
US5139939A (en) Process for the production of human tissue plasminogen activator and cell strain useful therefor
JPH0556951B2 (fr)
Harakas et al. Large‐scale purification of tissue‐type plasminogen activator from cultured human cells
US5234686A (en) Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
EP0275282A1 (fr) Procede de purification d'un activateur de plasminogene
EP0358274B1 (fr) Méthode de purification de l'activateur tissulaire du plasminogène
CA2262751A1 (fr) Activateur du plasminogene activable par thrombine
WO1996017928A1 (fr) Utilisation du domaine protease de l'activateur plasminogene humain dans le traitement de maladies thromboemboliques
OGISO et al. Measurement of human urokinase activity in plasma by using mono-specific antibody-conjugated paper disk
MXPA99000966A (en) Plasminogen activator capable of being activated by thrombin